Meclofenoxate, also known as Centrophenoxine, is a synthetic cholinergic compound primarily investigated for its potential cognitive-enhancing, anti-aging, and neuroprotective properties. It is structurally a DMAE (dimethylaminoethanol) ester of p-chlorophenoxyacetic acid and has been studied since the 1950s in both human and animal models. Researchers are particularly interested in its ability to enhance acetylcholine levels, support brain cell metabolism, and combat oxidative stress — especially in studies focusing on aging brains and cognitive disorders.

• Cognitive Enhancement: Meclofenoxate is frequently studied for its potential to improve short-term memory, learning ability, and mental clarity, particularly in aging subjects and models of cognitive impairment.

• Neuroprotection: It may reduce cellular damage by lowering levels of lipofuscin and oxidative stress markers, which are key indicators of age-related neuronal degradation.

• Choline Activity: As a DMAE-based compound, it increases acetylcholine synthesis in the brain, making it a useful agent in cholinergic neurotransmission studies.

• Anti-Aging Potential: Meclofenoxate has shown promise in reversing some signs of brain aging in rodent studies, including improved synaptic responsiveness and reduced waste accumulation in neurons.

• Brain Energy Metabolism: It supports glucose uptake and utilization in the brain, which is crucial for maintaining cognitive performance in aging subjects.

• Memory Preservation: Research shows it may delay the onset of memory loss in neurodegenerative disease models, including Alzheimer’s-related studies.

• Behavioral Studies: It is often used in maze tests and learning paradigms to evaluate attention, recognition, and memory in laboratory animals.

In controlled research environments, Meclofenoxate is typically administered via oral or injectable routes, depending on the species being studied and the specific research objectives. Its water solubility allows for flexible preparation in solution form, making it convenient for both acute and chronic dosing studies.

• Oral Administration: Often mixed into a buffered solution or suspension for ingestion in rodent models, enabling long-term studies on learning, memory, and mood.

• Intraperitoneal Injection (i.p.): Commonly used in animal studies requiring precise dosing, this method ensures fast systemic absorption and controlled variable analysis.

• Water-Soluble Form: The hydrochloride salt form of Meclofenoxate dissolves easily in water, allowing for straightforward dosage preparation in laboratory settings.

• Controlled Dosing: Researchers typically measure doses in mg/kg based on body weight, ensuring dosage accuracy across test groups.

• Chronic vs. Acute Studies: Used in both short-term memory evaluations and long-term neuroprotection studies, depending on research goals.

• Preparation in Sterile Conditions: In sterile injection research, it is prepared in isotonic saline under laminar flow hoods to prevent contamination.

• Combined Administration: In certain experiments, Meclofenoxate is administered alongside other compounds (e.g., racetams or antioxidants) to evaluate synergistic or antagonistic interactions.

Research on Meclofenoxate has identified a wide array of potential benefits, particularly in fields focusing on cognition, neurodegeneration, and cellular aging. While it is not approved for medical use, preclinical and limited clinical data suggest it may offer functional support for brain cell maintenance and memory-related processes.

• Enhanced Learning and Memory: Numerous studies have shown improved performance in spatial recognition tasks and learning tests among aged rodents and neuro-impaired animal models.

• Increased Brain Energy Output: Meclofenoxate facilitates the uptake and use of glucose and oxygen in neurons, helping fuel mental activity and prevent age-related decline in energy metabolism.

• Reduction of Oxidative Stress: It reduces markers such as malondialdehyde and lipofuscin — key indicators of free radical damage and cellular aging.

• Improved Synaptic Plasticity: There is evidence that it enhances communication between neurons, particularly in hippocampal and cortical regions responsible for memory.

• Mood and Motivation Enhancement: In animal models, it has shown subtle anxiolytic and mood-stabilizing effects, possibly due to its cholinergic modulation.

• Reduction of Neurological Inflammation: Some studies show lowered inflammatory markers in brain tissue, suggesting a protective role in degenerative conditions.

• Long-Term Neuroprotection: Prolonged exposure in lab animals has resulted in preserved cognitive performance and neuronal integrity into advanced age.

Meclofenoxate is not classified as a controlled substance in most jurisdictions, and its use for research purposes is widely legal. However, it is not approved for human consumption or medical treatment in the United States or many other countries.

• United States (USA): Meclofenoxate is unscheduled and legal to purchase for research purposes. It is not FDA-approved for medical or dietary use.

• European Union (EU): Generally permitted for scientific use, though some EU countries may have regulations around import or resale that must be adhered to.

• United Kingdom (UK): It is legal for laboratory use but not classified as a medicine or supplement.

• Import Requirements: When ordering internationally, customs may require documentation proving that the product is for research only and not for human consumption.

• No Prescription Needed: RC Plug does not require a prescription to purchase Meclofenoxate for legitimate scientific purposes.

• Labeling Compliance: Products are clearly labeled as “Not for Human Consumption” and intended solely for use by qualified researchers.

• Educational Institutions and Labs: Commonly used in academic and industrial research, provided that safety and legal protocols are followed.

Yes, Meclofenoxate is frequently included in combination studies to evaluate synergistic or cumulative cognitive and neuroprotective effects. Stacking allows researchers to assess the compound’s efficacy in multi-target approaches to memory, neurochemistry, and aging.

• Choline Synergy: Commonly combined with Alpha-GPC or CDP-Choline to amplify acetylcholine synthesis and examine impacts on memory retention and executive function.

• With Racetams: Often paired with Piracetam, Aniracetam, or Oxiracetam in comparative cognition studies to test for potentiation or attenuation of cognitive markers.

• With Antioxidants: Stacked with Coenzyme Q10, N-Acetylcysteine, or ALCAR in oxidative stress models to evaluate cell resilience and lifespan.

• Mood-Related Compounds: Occasionally studied alongside adaptogens or serotoninergic compounds to observe secondary mood-stabilizing effects.

• Anti-Aging Protocols: Included in long-term studies with compounds like Selegiline or Deprenyl in models focused on neurodegeneration and lifespan extension.

• Neurogenesis Investigations: Used with agents like Lion’s Mane extract or NSI-189 to explore brain regeneration and hippocampal plasticity.

• Placebo-Controlled Trials: Often structured with baseline controls, individual compound groups, and stacked combinations for clear comparative data.

When working with Meclofenoxate in a research environment, it’s essential to follow strict safety protocols to ensure both user protection and the integrity of experimental data. While it is not considered highly hazardous, its classification as a research chemical mandates responsible handling, proper labeling, and compliance with relevant lab safety guidelines.

• Personal Protective Equipment (PPE): Researchers should wear gloves, lab coats, and respiratory masks when handling the powder to prevent accidental inhalation or skin contact.

• Proper Storage: Meclofenoxate should be kept in airtight containers in a cool, dark, and dry environment. Exposure to moisture, heat, or light can degrade the compound’s potency.

• Clear Labeling: Containers must be clearly marked “For Research Use Only – Not for Human Consumption” to avoid misuse and ensure compliance with institutional protocols.

• Avoid Cross-Contamination: Workspaces should be sanitized before and after use, and dedicated tools should be used to avoid contaminating other chemicals or samples.

• Precision in Measurement: Use calibrated microbalances and dosing equipment to ensure accurate administration in test models. Improper dosing can skew results or cause unintended side effects.

• Ventilation and Fume Hood Usage: When preparing solutions or handling bulk powder, use a fume hood or ensure the workspace is well-ventilated to minimize airborne particles.

• Waste Disposal Compliance: Dispose of any unused product, containers, or contaminated materials according to local chemical waste disposal regulations.

Meclofenoxate is a modified form of DMAE (Dimethylaminoethanol), designed to improve bioavailability and neurological efficacy. While both share similar cholinergic properties, Meclofenoxate has several advantages in laboratory settings due to its enhanced pharmacokinetic profile and additional functional groups.

• Improved Bioavailability: Meclofenoxate is an esterified version of DMAE, allowing it to cross the blood-brain barrier more effectively in animal models, leading to higher cerebral uptake.

• Dual Functionality: It combines DMAE with p-chlorophenoxyacetic acid, giving it antioxidant and neuroprotective properties that DMAE alone does not exhibit.

• Longer Duration of Action: Meclofenoxate has a longer half-life in vivo, sustaining its effects on cognitive parameters longer than DMAE in comparative studies.

• Stronger Cholinergic Activity: It more efficiently enhances acetylcholine synthesis, making it preferable in studies that target neurotransmitter modulation.

• Reduced Peripheral Activity: Unlike DMAE, which may produce stimulatory effects on the body, Meclofenoxate is more centralized in its effects due to its focused brain-targeting profile.

• Less Likely to Cause Side Effects: DMAE has been associated with overstimulation and muscle tension at higher doses, while Meclofenoxate tends to present a more favorable tolerability in lab studies.

Understanding the pharmacokinetics of Meclofenoxate is important for planning appropriate observation windows in research. Although precise timing varies between test subjects and dosage forms, studies have shown that its active effects are relatively fast-acting and moderate in duration.

• Onset of Action: Meclofenoxate typically begins to exert effects within 30 to 60 minutes of administration, depending on the route used.

• Active Duration: Cognitive or neurological effects generally persist for 4 to 6 hours in rodents and small animals, making it suitable for half-day protocols.

• Plasma Half-Life: Estimated half-life in animal studies ranges between 2.5 and 4 hours, with peak plasma concentrations observed in under 1 hour.

• Consistent Delivery: In chronic dosing studies, Meclofenoxate maintains stable levels without excessive accumulation, making it viable for long-term administration protocols.

• Metabolic Breakdown: It is rapidly metabolized into DMAE and p-chlorophenoxyacetic acid, both of which are cleared through renal pathways.

Yes, Meclofenoxate is highly water-soluble, which enhances its versatility in research environments. This characteristic makes it convenient to work with and ideal for preparation in a wide range of lab-based experimental protocols.

• High Solubility Profile: The hydrochloride salt of Meclofenoxate dissolves easily in distilled or deionized water, eliminating the need for complex solvents.

• Ease of Preparation: Researchers can prepare oral suspensions, injectable solutions, or dilutions without heating or prolonged agitation.

• Solution Stability: In properly sealed containers, prepared aqueous solutions maintain stability for extended periods under refrigeration.

• Precise Dosing: Water solubility allows for accurate microdosing and concentration adjustments, essential for controlled lab experiments.

• In Vivo Administration: Its solubility supports both enteral (oral) and parenteral (injection) delivery systems in animal testing.

• Compatibility with Buffers: Meclofenoxate is stable in a variety of pH environments and can be used with common biological buffers such as PBS or saline.

Proper storage is vital to maintain the stability, purity, and effectiveness of Meclofenoxate over time. Because this compound is hygroscopic and sensitive to light, controlled storage conditions are essential for preserving its research-grade quality.

• Cool Temperature Range: Store Meclofenoxate between 2°C and 8°C to minimize degradation. Avoid freezing, as it may affect consistency when thawed.

• Dry Storage: Use moisture-proof containers with desiccants if possible. The compound can absorb atmospheric moisture, which leads to clumping or chemical breakdown.

• Dark Environment: Protect from direct light, especially UV rays, which can destabilize the chemical bonds and reduce potency.

• Airtight Containers: Use vacuum-sealed or tightly closed vials to prevent exposure to air and humidity.

• Labeling and Dating: Always label containers with the product name, lot number, and opening date to ensure proper inventory tracking and traceability.

• Avoid Frequent Opening: Minimize the number of times the container is opened to prevent contamination and repeated exposure to oxygen or moisture.

• Refrigerated Storage: Meclofenoxate remains stable for extended periods in refrigerated lab storage, especially in low-light environments such as closed drawers or scientific fridges.

Meclofenoxate operates through a multifaceted mechanism that centers around cholinergic neurotransmission, membrane stability, and cellular repair processes. Once ingested or administered in animal models, it is hydrolyzed into DMAE and p-chlorophenoxyacetic acid, both of which contribute to its observed neurological and metabolic effects. These interactions make Meclofenoxate a compound of interest in studies focused on cognition, aging, and oxidative stress.

• Acetylcholine Enhancement: Meclofenoxate increases the availability of choline in the brain, which leads to elevated synthesis of acetylcholine — a key neurotransmitter involved in memory and learning.

• Neurotransmitter Modulation: By improving cholinergic transmission, it facilitates better communication between neurons, particularly in regions like the hippocampus and prefrontal cortex.

• Antioxidant Activity: It reduces lipid peroxidation and scavenges free radicals, contributing to the protection of neuronal membranes against oxidative damage.

• Membrane Phospholipid Support: The compound helps stabilize cell membranes and supports their repair, which is particularly relevant in studies involving aging or toxin exposure.

• RNA Synthesis Activation: Research shows that Meclofenoxate can increase RNA production in brain cells, potentially improving protein synthesis and cellular renewal.

• Lipofuscin Clearance: It promotes the reduction of lipofuscin deposits, an age-related waste product that accumulates in neural tissue.

• Mitochondrial Support: It may enhance energy metabolism by improving mitochondrial function, contributing to better neuronal performance under stress.

In preclinical research and limited clinical observation, Meclofenoxate is generally well-tolerated. However, side effects have been documented, particularly at higher doses or with prolonged exposure. Understanding these effects is essential for setting safe parameters in laboratory research protocols.

• Mild Hyperstimulation: Some animal models exhibit increased physical activity or restlessness, particularly in acute dosage studies.

• Headache or Tension: At high doses, Meclofenoxate may induce tension headaches in rodents, likely due to cholinergic overstimulation.

• Insomnia or Sleep Disruption: Depending on the timing and dose, it may affect circadian activity or sleep cycles in nocturnal lab animals.

• Gastrointestinal Changes: Occasional nausea, mild diarrhea, or appetite suppression have been noted in oral administration trials.

• Irritability or Anxiety: While rare, some behavioral tests show signs of increased anxiety or aggression, especially when combined with other stimulatory compounds.

• Dose-Dependent Severity: Side effects are more likely to appear in dosages that exceed the typical mg/kg ratios used in cognitive studies.

• Reversibility: Most side effects resolve quickly upon withdrawal or dose reduction, indicating that Meclofenoxate is not inherently toxic at research concentrations.

Yes, Meclofenoxate is frequently utilized in studies focusing on age-related cognitive decline. Its dual-action on neurotransmission and cellular rejuvenation makes it an ideal candidate for investigating interventions in neurological aging. It has been studied extensively in aged animal models, showing consistent benefits in areas such as memory retention, attention span, and overall brain vitality.

• Memory Preservation: In elderly rodents, long-term administration helps preserve spatial and working memory, often outperforming control substances.

• Lipofuscin Reduction: One of its most unique traits is its ability to reduce age-induced lipofuscin buildup, which is linked to neuron degeneration.

• Improved Neuronal Plasticity: Age-related decline in synaptic responsiveness is partially reversed in test subjects administered Meclofenoxate chronically.

• Neuroinflammation Reduction: It modulates inflammatory cytokines that typically rise with age and contribute to neuronal damage.

• Enhanced Brain Metabolism: Older brains treated with Meclofenoxate show improved glucose utilization and mitochondrial efficiency.

• Longevity Applications: Some animal studies indicate lifespan extension benefits, particularly in relation to brain health and cognitive function.

• Prevention of Cognitive Decline: In combination protocols, it is evaluated for its ability to prevent early-stage memory loss and mild cognitive impairment in aging models.

Meclofenoxate is referred to by several names across scientific literature, research publications, and regional pharmaceutical catalogs. Being aware of these synonyms ensures proper recognition in data interpretation, cross-referencing, and procurement across regulatory environments.

• Centrophenoxine: This is the most common alternative name and is often used interchangeably with Meclofenoxate in published research.

• Lucidril: A former brand name under which the compound was marketed in European and Asian markets, especially for memory-related applications.

• DMAE Ester: Reflects its chemical composition, indicating that it is an esterified form of dimethylaminoethanol.

• Dimethylaminoethyl p-chlorophenoxyacetate: The full chemical descriptor, often used in analytical and pharmacological studies.

• Meclofenoxate Hydrochloride: This refers to the most common salt form used in research-grade preparations due to its stability and water solubility.

• Nootropic Choline Donor: Descriptive phrase often used in reviews or classification charts in nootropic and neuroenhancement studies.

Purity analysis of Meclofenoxate is critical in ensuring that research findings are valid and reproducible. At RC Plug, we only supply Meclofenoxate that has passed multi-stage testing using advanced instrumentation. These techniques help confirm both chemical identity and quantitative purity.

• High-Performance Liquid Chromatography (HPLC): This method is used to determine compound concentration and identify impurities down to the parts-per-million level.

• Gas Chromatography-Mass Spectrometry (GC-MS): Confirms molecular structure and detects volatile contaminants or synthetic by-products.

• Fourier-Transform Infrared Spectroscopy (FTIR): Measures bond structures and provides a unique spectrum to verify compound identity.

• Melting Point Analysis: Used as a rapid method to detect impurities that alter the melting behavior of the substance.

• Moisture Content Testing: Determines hygroscopic levels to ensure proper handling and packaging conditions have been maintained.

• Microbial Contamination Testing: Screened for bacterial, fungal, or endotoxin presence, especially important in injection-based research studies.

• Certificate of Analysis (COA): Every batch of Meclofenoxate we distribute includes a COA detailing its purity, testing methods used, and results.